Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Salicylate | HCID 8365 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Reactant | N-(6-iodoimidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide | HCID 57386058 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 57505638 | HCID 57505638 | 18% |
Reaction Steps
To a solution of ethyl salicylate (1010 mg, 6.1 mmol) in N,N-dimethylformamide (8 mL) was added potassium tert-butoxide (840 mg, 6.4 mmol) at 0° C., and the mixture was stirred at 0° C. for 5 min and at room temperature for 25 min. To the reaction mixture were added N-(6-iodoimidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide (1.0 g, 3.1 mmol) and potassium carbonate (420 mg, 3.1 mmol), and the mixture was stirred at 100° C. for 24 hr. The solvent was evaporated under reduced pressure, ethyl acetate/tetrahydrofuran and water were added to the residue. The aqueous layer was extracted with ethyl acetate/tetrahydrofuran (×3). Combined organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and filtrated. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate/hexane=40/60→90/10) to give ethyl 2-({2[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)benzoate (200 mg, 18%) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08034812B2 |
|---|
| Source dataset | uspto-grants-2011_10 |
|---|
| ORD ID | ord-ea365d0348be49c6911de04524d57715 |
|---|
| Source note | uspto-grants-2011_10 |
|---|